Paraquat Litigation Progress: Positive For Plaintiffs

We continue to investigate lawsuits for those who have been exposed to Paraquat – a popular herbicide that is not only linked to Parkinson’s Disease but also banned in more than 60 countries due to its potential health hazards.

As of early April, there are 5,859 claims being litigated in the Paraquat multidistrict litigation (MDL). This MDL structure helps streamline the legal process for thousands of cases, ensuring efficient handling of evidence and testimonies. Despite the dynamic nature of the litigation process, many claims face the prospect of dismissal due to noncompliance with procedural requirements, such as the timely submission of Plaintiff Assessment Questionnaires (PAQs).

Renewed Confidence for Plaintiffs

Recent developments have brought renewed confidence to plaintiffs after a series of setbacks. On April 14, 2025, a joint statement was filed that could lead to the settlement of the majority of Paraquat cases. This came just days after the abrupt cancellation of the MDL case management conference.

Importance of the Plaintiff Assessment Questionnaire (PAQ)

The latest special master’s report highlights that around 100 cases are on the verge of dismissal due to noncompliance with the Plaintiff Assessment Questionnaire (PAQ) deadlines. In multi-district litigations, the PAQ is crucial as it serves as sworn testimony. It provides evidence that defendants can review and cross-examine, similar to live testimony or a deposition. Timely submission of the PAQ is essential to keep claims viable and avoid dismissal.

Navigating The Negotiations

The people involved have asked the court to pause the seventh circuit appeal because they are starting to agree on a settlement. Judge Nancy Rosenstengel is okay with this and wants to help things move smoothly. In the next 60 days, we’ll find out what the requirements are for the settlement and what will affect the value of the claims.

We are optimistic about these developments. They show progress and a positive outlook for plaintiffs seeking resolution in their Paraquat claims.